Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 Trial.

Details

Language :

English

ISSN :

10795642

Volume :

43

Issue :

8

Database :

Complementary Index

Journal :

Arteriosclerosis, Thrombosis & Vascular Biology

Publication Type :

Academic Journal

Accession number :

170713807

Full Text :

https://doi.org/10.1161/ATVBAHA.122.318748